0001179110-14-000628.txt : 20140107
0001179110-14-000628.hdr.sgml : 20140107
20140107165403
ACCESSION NUMBER: 0001179110-14-000628
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140103
FILED AS OF DATE: 20140107
DATE AS OF CHANGE: 20140107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Christopher G
CENTRAL INDEX KEY: 0001537668
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 14514055
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
edgar.xml
FORM 4 -
X0306
4
2014-01-03
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001537668
White Christopher G
1100 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Chief Business Officer
Common Stock
2014-01-06
4
S
0
2500
23.69
D
31334
D
Common Stock
2014-01-07
4
S
0
2500
24.10
D
28834
D
The shares reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.30 - $23.95. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
This total includes 5,000 shares delivered to the reporting person on January 3, 2014 pursuant to the partial vesting of a restricted stock unit award granted to the reporting person on January 3, 2012 and of which 2,500 shares were sold on January 6, 2014 as reported in this Form 4. This total also includes 834 unvested restricted stock units granted on February 24, 2010, 8,000 unvested restricted stock units granted pursuant to two separate grants on January 7, 2011, and 5,000 unvested restricted stock units granted on January 3, 2012, all of which were previously reported on Table II. Thus, after taking into account the delivery of shares on January 3, 2014, this total includes an aggregate of 18,834 unvested restricted stock units previously reported on Table II.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.84 - $24.82. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
Nancy R. Smith, attorney-in-fact
2014-01-07